Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gaglani, M. J.
Right arrow Articles by Herschler, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaglani, M. J.
Right arrow Articles by Herschler, G. B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Every Nose Counts: A New Influenza Vaccine for All Healthy Schoolchildren?

Manjusha J. Gaglani, MBBS

Section of Pediatric Infectious Diseases, Scott & White Memorial Hospital/Clinic, Scott, Sherwood and Brindley Foundation, Texas A&M University System Health Science Center College of Medicine, Temple, Texas

Gayla B. Herschler, MSN, RNC

Section of Pediatric Infectious Diseases, Scott & White Memorial Hospital/Clinic, Scott, Sherwood and Brindley Foundation, Texas A&M University System Health Science Center College of Medicine, Temple, Texas

Influenza is a vaccine-preventable disease. However, influenza virus spreads among children in schools and daycare centers, then to families and communities, causing uncontrolled epidemics every winter. The United States Food and Drug Administration evaluated and approved an investigational live-attenuated, cold-adapted, trivalent influenza vaccine for licensure, for prevention of influenza in healthy children and healthy adults, 5 through 49 years of age. Could protection of healthy schoolchildren against influenza limit its spread and benefit society?

Clinical Pediatrics, Vol. 43, No. 1, 35-41 (2004)
DOI: 10.1177/000992280404300105
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?